Education
About Us
Working with TipRanks
Follow Us
Camurus AB (SE:CAMX)
:CAMX
CAMX Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr483.80 - kr715.00
Previous CloseN/A
Volume19.01K
Average Volume (3M)239.94K
Market Cap
kr41.86B
Enterprise Valuekr37.11B
Total Cash (Recent Filing)kr2.88B
Total Debt (Recent Filing)kr106.64M
Price to Earnings (P/E)57.5
Beta0.77
Next Earnings
Nov 06, 2025EPS Estimate
3.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.08
Shares Outstanding59,626,984
10 Day Avg. Volume133,058
30 Day Avg. Volume239,939
Financial Highlights & Ratios
PEG Ratio2.67
Price to Book (P/B)11.34
Price to Sales (P/S)0.00
P/FCF Ratio108.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr657.01Price Target Upside-6.41% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Camurus AB News
PremiumCompany Announcements
Camurus AB Reports Strong Q2 2025 Financial Results
PremiumCompany Announcements
Camurus Reports Robust Growth in Q2 2025
PremiumCompany Announcements
Camurus’ Oczyesa Gains EU Approval for Acromegaly Treatment
PremiumCompany Announcements
Camurus Expands Share Count to Support Employee Incentive Program
PremiumCompany Announcements
Camurus’ POSITANO Study Shows Promising Results for PLD Treatment
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.39%
Mutual Funds
― Other Institutional Investors
93.33% Public Companies and
Individual Investors
CAMX FAQ
What was Camurus AB’s price range in the past 12 months?
Camurus AB lowest stock price was kr483.80 and its highest was kr715.00 in the past 12 months.
What is Camurus AB’s market cap?
Camurus AB’s market cap is kr41.86B.
When is Camurus AB’s upcoming earnings report date?
Camurus AB’s upcoming earnings report date is Nov 06, 2025 which is in 108 days.
How were Camurus AB’s earnings last quarter?
Camurus AB released its earnings results on Jul 17, 2025. The company reported kr4.08 earnings per share for the quarter, beating the consensus estimate of kr3.419 by kr0.661.
Is Camurus AB overvalued?
According to Wall Street analysts Camurus AB’s price is currently Overvalued.
Does Camurus AB pay dividends?
Camurus AB does not currently pay dividends.
What is Camurus AB’s EPS estimate?
Camurus AB’s EPS estimate is 3.68.
How many shares outstanding does Camurus AB have?
Camurus AB has 59,626,984 shares outstanding.
What happened to Camurus AB’s price movement after its last earnings report?
Camurus AB reported an EPS of kr4.08 in its last earnings report, beating expectations of kr3.419. Following the earnings report the stock price went up 0.58%.
Which hedge fund is a major shareholder of Camurus AB?
Currently, no hedge funds are holding shares in SE:CAMX
Company Description
Camurus AB
Camurus AB is a Swedish biopharmaceutical company specializing in the development and commercialization of innovative pharmaceuticals for the treatment of serious and chronic diseases. The company focuses primarily on areas such as addiction, pain, cancer, and endocrine disorders. Camurus is known for its proprietary FluidCrystal® technology which enables the development of advanced drug delivery systems.
CAMX Company Deck
CAMX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented strong financial performance and growth in key product sales, along with a solid cash position. However, challenges such as the FDA's CRL and increased operating expenses were noted. The positive aspects of growth and profitability were more pronounced, leading to an optimistic outlook.Read More>Technical Analysis
Hansa Biopharma AB
―
BioArctic AB Class B
―
Xbrane Biopharma AB
―
Xspray Pharma AB
―
SynAct Pharma AB
―